Posted On: 06/17/2016 1:00:08 PM
Post# of 72443
Reminder: Two Brilacidin presentations this weekend.
Pharmacokinetic-pharmacodynamic(Pk?Pd) Analyses for Efficacy and Safety of Brilacidin (Bri) Using Data fromPatients with Acute Bacterial Skin and Skin Structure Infections (Absssi)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18058
Application of Pharmacokinetic-Pharmacodynamic (Pk-Pd) Models for Brilacidin (Bri) Dose Selection Support for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18096
Pharmacokinetic-pharmacodynamic(Pk?Pd) Analyses for Efficacy and Safety of Brilacidin (Bri) Using Data fromPatients with Acute Bacterial Skin and Skin Structure Infections (Absssi)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18058
Application of Pharmacokinetic-Pharmacodynamic (Pk-Pd) Models for Brilacidin (Bri) Dose Selection Support for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18096
(1)
(0)
Scroll down for more posts ▼
